Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence.

Hausmann D, Bittencourt LK, Attenberger UI, Sertdemir M, Weidner A, Büsing KA, Brade J, Wenz F, Schoenberg SO, Dinter DJ.

Clin Nucl Med. 2014 Mar;39(3):e197-201. doi: 10.1097/RLU.0b013e3182a23d37.

PMID:
24092230
2.

Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.

Beheshti M, Haim S, Zakavi R, Steinmair M, Waldenberger P, Kunit T, Nader M, Langsteger W, Loidl W.

J Nucl Med. 2013 Jun;54(6):833-40. doi: 10.2967/jnumed.112.110148. Epub 2013 Apr 4.

3.

Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates.

Krause BJ, Souvatzoglou M, Treiber U.

Urol Oncol. 2013 May;31(4):427-35. doi: 10.1016/j.urolonc.2010.08.008. Epub 2011 Mar 8. Review.

PMID:
21388835
4.

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

Poulsen MH, Bouchelouche K, Høilund-Carlsen PF, Petersen H, Gerke O, Steffansen SI, Marcussen N, Svolgaard N, Vach W, Geertsen U, Walter S.

BJU Int. 2012 Dec;110(11):1666-71. doi: 10.1111/j.1464-410X.2012.11150.x. Epub 2012 Apr 23.

5.

Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.

Kitajima K, Murphy RC, Nathan MA, Froemming AT, Hagen CE, Takahashi N, Kawashima A.

J Nucl Med. 2014 Feb;55(2):223-32. doi: 10.2967/jnumed.113.123018. Epub 2014 Jan 16.

6.

Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT.

Wetter A, Lipponer C, Nensa F, Heusch P, Rübben H, Altenbernd JC, Schlosser T, Bockisch A, Pöppel T, Lauenstein T, Nagarajah J.

Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):79-88. doi: 10.1007/s00259-013-2560-2. Epub 2013 Oct 2.

PMID:
24085502
7.

Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.

Li CY, Klohr S, Sadick H, Weiss C, Hoermann K, Schoenberg SO, Sadick M.

J Nucl Med Technol. 2014 Sep;42(3):181-7. doi: 10.2967/jnmt.114.141192. Epub 2014 Jun 26.

8.

Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results.

Nanni C, Schiavina R, Boschi S, Ambrosini V, Pettinato C, Brunocilla E, Martorana G, Fanti S.

Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1:S11-7. doi: 10.1007/s00259-013-2373-3. Epub 2013 Apr 17.

PMID:
23591953
9.

18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.

Nanni C, Schiavina R, Brunocilla E, Borghesi M, Ambrosini V, Zanoni L, Gentile G, Vagnoni V, Romagnoli D, Martorana G, Fanti S.

Clin Genitourin Cancer. 2014 Apr;12(2):106-10. doi: 10.1016/j.clgc.2013.08.002. Epub 2013 Oct 14.

PMID:
24135632
10.

Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence.

Steiner Ch, Vees H, Zaidi H, Wissmeyer M, Berrebi O, Kossovsky MP, Khan HG, Miralbell R, Ratib O, Buchegger F.

Nuklearmedizin. 2009;48(1):1-9; quiz N2-3.

PMID:
19212605
11.

18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT.

Nanni C, Schiavina R, Brunocilla E, Boschi S, Borghesi M, Zanoni L, Pettinato C, Martorana G, Fanti S.

Clin Nucl Med. 2015 Aug;40(8):e386-91. doi: 10.1097/RLU.0000000000000849.

PMID:
26053708
12.

Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.

Rietbergen DD, van der Hiel B, Vogel W, Stokkel MP.

Nucl Med Commun. 2011 Dec;32(12):1143-7. doi: 10.1097/MNM.0b013e32834b76fa.

PMID:
22045476
13.

¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.

D'Angelillo RM, Sciuto R, Ramella S, Papalia R, Jereczek-Fossa BA, Trodella LE, Fiore M, Gallucci M, Maini CL, Trodella L.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):296-302. doi: 10.1016/j.ijrobp.2014.05.050. Epub 2014 Jul 29.

PMID:
25084612
14.

Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.

Schwarzenböck SM, Kurth J, Gocke Ch, Kuhnt T, Hildebrandt G, Krause BJ.

Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1:S28-35. doi: 10.1007/s00259-013-2404-0. Epub 2013 Apr 11. Review.

PMID:
23576101
15.

Value of fused 18F-Choline-PET/MRI to evaluate prostate cancer relapse in patients showing biochemical recurrence after EBRT: preliminary results.

Piccardo A, Paparo F, Piccazzo R, Naseri M, Ricci P, Marziano A, Bacigalupo L, Biscaldi E, Rollandi GA, Grillo-Ruggieri F, Farsad M.

Biomed Res Int. 2014;2014:103718. doi: 10.1155/2014/103718. Epub 2014 Apr 30. Erratum in: Biomed Res Int. 2016;2016:5047948. Biomed Res Int. 2016;2016:5047948. Picazzo, Riccardo [corrected to Piccazzo, Riccardo].

16.

Phantom studies and clinical application of high resolution, image reconstruction using (18)F-fluoromethylcholine PET/CT for prostate cancer.

Zielinski A, Behrendt FF, Verburg FA, Mottaghy FM, Krohn T.

Hell J Nucl Med. 2014 Sep-Dec;17(3):194-9. doi: 10.1967/s002449910145. Epub 2014 Nov 12.

17.

18F-Choline Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for the Detection of Early Local Recurrence of Prostate Cancer Initially Treated by Radiation Therapy: Comparison With Systematic 3-Dimensional Transperineal Mapping Biopsy.

Kanoun S, Walker P, Vrigneaud JM, Depardon E, Barbier V, Humbert O, Moulin M, Créhange G, Cormier L, Loffroy R, Brunotte F, Cochet A.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):986-994. doi: 10.1016/j.ijrobp.2016.12.025. Epub 2016 Dec 28.

PMID:
28333020
18.

Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.

Koopman D, van Dalen JA, Lagerweij MC, Arkies H, de Boer J, Oostdijk AH, Slump CH, Jager PL.

J Nucl Med Technol. 2015 Mar;43(1):21-7. doi: 10.2967/jnmt.114.147215. Epub 2015 Jan 22.

19.

18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.

Tilki D, Reich O, Graser A, Hacker M, Silchinger J, Becker AJ, Khoder W, Bartenstein P, Stief CG, Loidl W, Seitz M.

Eur Urol. 2013 May;63(5):792-6. doi: 10.1016/j.eururo.2012.08.003. Epub 2012 Aug 10.

PMID:
22902037
20.

Prognostic value of metabolic parameters and clinical impact of ¹⁸F-fluorocholine PET/CT in biochemical recurrent prostate cancer.

Colombié M, Campion L, Bailly C, Rusu D, Rousseau T, Mathieu C, Ferrer L, Rousseau N, Kraeber-Bodéré F, Rousseau C.

Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1784-93. doi: 10.1007/s00259-015-3123-5. Epub 2015 Jul 21.

PMID:
26194716

Supplemental Content

Support Center